BMC Cancer 2009, 9:398 http://www.biomedcentral.com/1471-2407/9/398 bPFleiogrocudernectea3lglse of ALS relative to controls after 2-h and 24-h of etoposide treatment for both non-stimulated and PHA stimulated Percentage of ALS relative to controls after 2-h and 24-h of etoposide treatment for both non-stimulated and PHA stimulated blood cells. Data were analyzed using one way Anova test. (* p < 0.05 vs. control; *** p < 0.001 vs. con- trol). sPFteiigmrcuuerlnaetae4gdebol ofoDdNcAel-lAsPtrseiatteesdre2l4a-thivewittoh ceotontprooslisdevidenced by Exo III in non-stimulated blood cells treated for 2-h and PHA- Percentage of DNA-AP sites relative to controls evidenced by Exo III in non-stimulated blood cells treated for 2-h and PHA-stimulated blood cells treated 24-h with etoposide. Data were analyzed using one way Anova test. (**p < 0.01 vs. control; ***p < 0.001 vs. control). Page 6 of 9 (page number not for citation purposes)